Company

Development of a specific syringe for wrinkle filler

Our customer contacts us to validate the design of a syringe made of plastic by injection molding, for wrinkle fillers with very high viscosity. Due to a very high concentration and modification degree, this leads us to the development and manufacture  of technical batches for the transport validation and shelf life, which is of great importance before the development of new products.

Explore our environment

  • Syrhatech completes a financinground of CHF 4.5 million

    Plan-les-Ouates, Geneva, April 2025 – Syrhatech, a French-Swiss CDMO innovating in thedevelopment and manufacture of…

  • Welcoming the New Year with Innovation and Leadership at SyrhaTech

    As we step into the New Year, SyrhaTech is excited to announce a significant addition…

  • Company

    Financing the future: SyrhaTech aims for new heights

    No company is more future-oriented at the moment than SyrhaTech: a Biotech medical device company…

  • Company

    SyrhaTech supports organization of ISHAS’s awards

    For the past four months, SyrhaTech has been in partnership with the learned society ISHAS…

    Partnership Syrhatech and ISHAS’s awards
  • Company

    SyrhaTech, an aesthetic medical device company, between France and Switzerland

    The SyrhaTech team is made up of people from Europe’s four corners. Everyone is very…

    SyrhaTech, an aesthetic medical device company
  • Company

    SyrhaTech joins CDMO France

    SyrhaTech is proud to announce that we have joined the “CDMO France” association. CDMO France…

    SyrhaTech joins CDMO France
  • Company

    They Trust SyrHA : The Excellence of a CDMO

    At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…

    Clients testimonials
  • Company

    Announcing strategic partnership : SyrHA the CDMO and ISHAS organization

    We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…

  • Company

    CDMO: Evolution of their role

    Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…

    CDMO: Evolution of their role
  • Company

     Join us at IMCAS Paris! 

    We’re delighted to announce that our team will be taking part in the IMCAS 2024…

    IMCAS 2024 World Congress in Paris